Lista de obras - Burçak Karaca - Dominio Público Uruguay

A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells.

artículo científico publicado en 2013

A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis.

artículo científico publicado en 2011

AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells

artículo científico publicado en 2017

Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

artículo científico publicado en 2014

Alveolar rhabdomyosarcoma originating from the uterine cervix.

artículo científico publicado en 2011

Aneurysmal circumflex coronary artery with fistulous connection to the coronary sinus

artículo científico publicado en 2005

Biweekly cetuximab in combination with platinum and 5-fluorouracil in metastatic head and neck carcinoma

scientific article published on 01 January 2019

Can gossypol be a hope for transsexual patients (male to female) before sex reassignment surgery? Just for adjusting the body to mind

artículo científico publicado en 2009

Cancer patients' satisfaction with doctors and preferences about death in a university hospital in Turkey.

artículo científico publicado en 2011

Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer.

artículo científico publicado en 2015

Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells.

artículo científico publicado en 2012

Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.

artículo científico publicado en 2015

Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells

artículo científico publicado en 2009

Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.

artículo científico publicado en 2005

Comparing time to disease progression of irinotecan and oxaliplatin-based chemotherapies in colorectal cancer patients with liver only metastasis.

artículo científico publicado en 2013

Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol).

artículo científico publicado en 2010

Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.

artículo científico publicado en 2015

Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

artículo científico publicado en 2008

Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines

artículo científico publicado en 2015

Does adoption of new technologies require high operative volume? Our results with sutureless aortic bioprostheses.

artículo científico publicado en 2015

Does the tumor localization in advanced pancreatic cancer have an influence on the management of symptoms and pain?

artículo científico publicado en 2010

Effects of Thymus serpyllum extract on cell proliferation, apoptosis and epigenetic events in human breast cancer cells

artículo científico publicado en 2012

Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients

artículo científico publicado en 2013

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer.

artículo científico publicado en 2009

Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines

artículo científico publicado en 2014

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.

artículo científico publicado en 2008

Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.

artículo científico publicado en 2010

Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer

Fanconi's anemia and squamous cell carcinoma of the larynx

scientific article published on 12 April 2003

Greater patient access to immuno-oncology therapies-what can policymakers do?

artículo científico publicado en 2015

Influence of medical education on students' attitudes towards the elderly

artículo científico publicado en 2006

Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs.

artículo científico publicado en 2009

Leptomeningeal carcinomatosis of gastric adenocarcinoma

artículo científico publicado en 2011

Middle East observational study in metastatic soft tissue sarcoma: an epidemiological study on the treatment patterns (MOON)

artículo científico publicado en 2018

Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.

artículo científico publicado en 2014

Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells

artículo científico publicado en 2015

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination.

artículo científico publicado en 2009

Pazopanib: a novel treatment option for aggressive fibromatosis

artículo científico publicado en 2016

Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.

artículo científico publicado en 2008

Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels.

artículo científico publicado en 2012

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol

artículo científico publicado en 2008

Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment

artículo científico publicado en 2010

Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

artículo científico publicado en 2010

Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

artículo científico publicado en 2009

Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315

scientific article published on 15 May 2015

Risk factors for poor mobilization in solid tumors: How effectively can we mobilize patients with solid tumors?

artículo científico publicado en 2017

Screening for metastasis in primary breast cancer patients having four or more axillary lymph node involvement: is it really necessary?

artículo científico publicado en 2010

Sexual dysfunction in cancer patients: a review

artículo científico

Surgical treatment of type A Acute Aortic Dissection based on Geneva algorithm.

artículo científico publicado en 2015

Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease

artículo científico publicado en 2013

Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.

artículo científico publicado en 2009

The Role of Body Mass Index in Triple Negative Breast Cancer.

artículo científico publicado en 2015

The frequency and significance of radiologically detected indeterminate pulmonary nodules in patients with colorectal cancer.

artículo científico publicado en 2012

Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells

scientific article published on 12 December 2019

Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer

artículo científico publicado en 2013

Undifferentiated embryonal sarcoma of the liver in an adult patient: case report

artículo científico publicado en 2012

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.

artículo científico publicado en 2012

Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines

artículo científico publicado en 2014

Lista de obras de Burçak Karaca

A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells.

A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis.

AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells

Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

Alveolar rhabdomyosarcoma originating from the uterine cervix.

Aneurysmal circumflex coronary artery with fistulous connection to the coronary sinus

Biweekly cetuximab in combination with platinum and 5-fluorouracil in metastatic head and neck carcinoma

Can gossypol be a hope for transsexual patients (male to female) before sex reassignment surgery? Just for adjusting the body to mind

Cancer patients' satisfaction with doctors and preferences about death in a university hospital in Turkey.

Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer.

Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells.

Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.

Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells

Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.

Comparing time to disease progression of irinotecan and oxaliplatin-based chemotherapies in colorectal cancer patients with liver only metastasis.

Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol).

Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.

Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines

Does adoption of new technologies require high operative volume? Our results with sutureless aortic bioprostheses.

Does the tumor localization in advanced pancreatic cancer have an influence on the management of symptoms and pain?

Effects of Thymus serpyllum extract on cell proliferation, apoptosis and epigenetic events in human breast cancer cells

Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients

Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer.

Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.

Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.

Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer

Fanconi's anemia and squamous cell carcinoma of the larynx

Greater patient access to immuno-oncology therapies-what can policymakers do?

Influence of medical education on students' attitudes towards the elderly

Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs.

Leptomeningeal carcinomatosis of gastric adenocarcinoma

Middle East observational study in metastatic soft tissue sarcoma: an epidemiological study on the treatment patterns (MOON)

Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.

Octreotide in combination with AT-101 induces cytotoxicity and apoptosis through up-regulation of somatostatin receptors 2 and 5 in DU-145 prostate cancer cells

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination.

Pazopanib: a novel treatment option for aggressive fibromatosis

Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.

Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels.

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol

Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment

Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315

Risk factors for poor mobilization in solid tumors: How effectively can we mobilize patients with solid tumors?

Screening for metastasis in primary breast cancer patients having four or more axillary lymph node involvement: is it really necessary?

Sexual dysfunction in cancer patients: a review

Surgical treatment of type A Acute Aortic Dissection based on Geneva algorithm.

Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease

Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.

The Role of Body Mass Index in Triple Negative Breast Cancer.

The frequency and significance of radiologically detected indeterminate pulmonary nodules in patients with colorectal cancer.

Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells

Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer

Undifferentiated embryonal sarcoma of the liver in an adult patient: case report

Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.

Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines